Navigation Links
Surefire Infusion System Found Safe and Effective for Delivery of 90Y in Treating Inoperable Liver Cancer
Date:7/10/2013

WESTMINSTER, Colo., July 10, 2013 /PRNewswire/ -- Case reports published in the Journal of Cardiovascular and Interventional Radiology found that by using the Surefire Infusion System, radioembolization could be successfully performed without the need to protect nearby blood vessels, a significant advance that may enable doctors to safely extend liver cancer treatment to patients who were previously deemed untreatable.

None of the three patients, including one who otherwise could not have been treated, suffered complications as a result of the minimally invasive procedure.  All were discharged the following day.

"With the protection from reflux afforded by Surefire's novel, expandable, funnel-shaped tip we performed successful yttrium-90 radioembolization without coiling," said Prof. Dr. Maurice van den Bosch, Interventional Radiologist, University Medical Center Utrecht, The Netherlands.  "Positron emission tomography-computed tomography (PET-CT) confirmed adequate, efficient biodistribution of the microspheres in targeted liver segments only."

In recent years, Interventional Oncology has emerged as a pillar of modern cancer care.  In numerous clinical studies, improved patient outcomes have been achieved with embolization therapy and systemic chemotherapy compared to systemic chemotherapy alone.

"We are gratified that our advanced technology enables a broader population of patients to be treated, including those who otherwise may not have received treatment," said Surefire Medical CEO Jim Chomas.  "These case studies add to the rapidly growing body of clinical evidence indicating that the Surefire Infusion System safely, efficiently and precisely delivers therapy.  It may contribute not only to enhanced treatment effectiveness, but also to the palliation of cancers to improve quality of life."

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop a new class of infusion systems for the interventional radiology and interventional oncology markets.  Surefire's infusion systems are designed to precisely deliver embolic agents through a unique microcatheter with an expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow in order to maximize targeted delivery, minimize reflux and reduce damage to healthy tissue.  For more information, please visit www.surefiremedical.com.


'/>"/>
SOURCE Surefire Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
2. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
3. Christopher Mennone Joins Surefire Medical Team As International Business Director
4. Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medicals Board of Directors
5. Study: Surefire Medicals Technology Improves Delivery Of Embolics In Cancer Treatment
6. Surefire Infusion System Used In Potential New Hunger-Reducing Obesity Treatment -- NIH Funds Johns Hopkins Study
7. Sirtex To Distribute Surefire Medicals Innovative Infusion System in Australia and Asia Pacific Markets
8. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
9. CareFusion Expands Infusion Pump Interoperability
10. Global Infusion Pumps Market 2011-2015
11. Riordan Lewis & Haden
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology:
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
Breaking Medicine News(10 mins):